Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

The EVInews database provides significantly higher quality information than web-based sources for pharmacists.

Precision medicine is crucial for early diagnosis and personalized treatment in prediabetes.

The document concluded that biomedical knowledge changes over time and the study evaluated a new method to track these changes.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

A new method organizes drug information to improve data use and create a comprehensive drug database.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Experts have pointed out key research in the area of regenerative medicine.

A new method makes analyzing large datasets with rare events faster and more efficient.

Collider bias can mislead our understanding of COVID-19 risk and severity.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Fine-tuned BERT models are better than LLMs for detecting bias in medical data.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

The document's conclusion cannot be provided because the document is not readable or understandable.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Innovative methods are reducing animal testing and improving biomedical research.

The N-K GM Series offers highly selective, eco-friendly medicines targeting harmful microbes, free for personal use.

The Ewha Medical Journal is now in PubMed, has an AI article editor, and offers Korean reporting guidelines.